Gozellix
Payments companies reported to CMS as associated with Gozellix. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Gozellix, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Gozellix
These are the largest totals companies reported as associated with Gozellix. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jaideep Sohi | Roseville, CA | Nuclear Radiology | $7,200.00 |
| Scott Tagawa | New York, NY | Hematology & Oncology | $228.50 |
| Jean-Luc Urbain | Buffalo, NY | Nuclear Imaging & Therapy | $128.79 |
| Ryan Avery | Chicago, IL | Diagnostic Radiology | $128.79 |
| Hemet Kherbache | Annandale, VA | Nuclear Imaging & Therapy | $128.79 |
| Ming Yang | Scottsdale, AZ | Diagnostic Radiology | $128.79 |
| Matthew Brady | Charleston, SC | Diagnostic Radiology | $128.79 |
| Stephen Scharf | New York, NY | Diagnostic Radiology | $128.79 |
| Vi Hua | Goodyear, AZ | Urology | $99.71 |
| Himanshu Nagar | New York, NY | Radiation Oncology | $99.71 |
Prescribed Gozellix?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.